OMNIAB INC (OABI) — insider trading
Health Care · NASDAQ
OMNIAB INC (OABI) has 38 reported SEC Form 4 insider transactions in our data, including 3 open-market sales among the most recent 38 (latest 2026-08-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-08-01 | Nwachuku Amechi Ekeke | Officer (Chief Operating Officer) | Grant / award / vesting (derivative) | 800,000 | — | $0 | Form 4 |
| 2026-06-17 | Love Steven | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-06-17 | Love Steven | Director | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Love Steven | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Love Steven | Director | Option exercise / conversion | 20,000 | — | — | Form 4 |
| 2026-06-17 | HIGGINS JOHN L | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-06-17 | HIGGINS JOHN L | Director | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | HIGGINS JOHN L | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | HIGGINS JOHN L | Director | Option exercise / conversion | 20,000 | — | — | Form 4 |
| 2026-06-17 | Gotwals Philip J | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-06-17 | Gotwals Philip J | Director | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Gotwals Philip J | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Gotwals Philip J | Director | Option exercise / conversion | 20,000 | — | — | Form 4 |
| 2026-06-17 | Crouse Steven C. | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-06-17 | Crouse Steven C. | Director | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Crouse Steven C. | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Crouse Steven C. | Director | Option exercise / conversion | 20,000 | — | — | Form 4 |
| 2026-06-17 | Cochran Jennifer R. | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-06-17 | Cochran Jennifer R. | Director | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Cochran Jennifer R. | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Cochran Jennifer R. | Director | Option exercise / conversion | 20,000 | — | — | Form 4 |
| 2026-06-17 | Bertozzi Carolyn R | Director | Grant / award / vesting (derivative) | 40,000 | — | $0 | Form 4 |
| 2026-06-17 | Bertozzi Carolyn R | Director | Grant / award / vesting (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Bertozzi Carolyn R | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-17 | Bertozzi Carolyn R | Director | Option exercise / conversion | 20,000 | — | — | Form 4 |
| 2026-04-21 | Crouse Steven C. | Director | Option exercise / conversion (derivative) | 13,333 | — | $0 | Form 4 |
| 2026-04-21 | Crouse Steven C. | Director | Option exercise / conversion | 13,333 | — | — | Form 4 |
| 2026-04-21 | Gotwals Philip J | Director | Option exercise / conversion (derivative) | 13,333 | — | $0 | Form 4 |
| 2026-04-21 | Gotwals Philip J | Director | Option exercise / conversion | 13,333 | — | — | Form 4 |
| 2026-04-07 | Berkman Charles S | Officer (Chief Legal Officer) | Option exercise / conversion (derivative) | 13,542 | — | $0 | Form 4 |
| 2026-04-07 | Berkman Charles S | Officer (Chief Legal Officer) | Open-market sale | 7,157 | $1.49 | $10.7K | Form 4 |
| 2026-04-07 | Berkman Charles S | Officer (Chief Legal Officer) | Option exercise / conversion | 13,542 | — | $0 | Form 4 |
| 2026-04-07 | GUSTAFSON KURT A | Officer (Executive VP, Finance and CFO) | Option exercise / conversion (derivative) | 13,542 | — | $0 | Form 4 |
| 2026-04-07 | GUSTAFSON KURT A | Officer (Executive VP, Finance and CFO) | Open-market sale | 6,913 | $1.49 | $10.3K | Form 4 |
| 2026-04-07 | GUSTAFSON KURT A | Officer (Executive VP, Finance and CFO) | Option exercise / conversion | 13,542 | — | $0 | Form 4 |
| 2026-04-07 | FOEHR MATTHEW W | Director, Officer (President and CEO) | Option exercise / conversion (derivative) | 36,459 | — | $0 | Form 4 |
| 2026-04-07 | FOEHR MATTHEW W | Director, Officer (President and CEO) | Open-market sale | 19,244 | $1.49 | $28.7K | Form 4 |
| 2026-04-07 | FOEHR MATTHEW W | Director, Officer (President and CEO) | Option exercise / conversion | 36,459 | — | $0 | Form 4 |
Ask the chat about OABI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: OMNIAB INC (OABI).
Last updated 2026-08-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.